查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1538491

酵母感染疾病治疗市场报告：2030 年趋势、预测与竞争分析

Yeast Infection Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

酵母菌感染疾病治疗的趋势与预测

到 2030 年，全球酵母菌感染疾病治疗市场预计将达到 79 亿美元，2024 年至 2030 年复合年增长率为 4.6%。这个市场的主要驱动因素是自体免疫疾病和酵母菌感染疾病的增加、感染疾病和过敏性疾病发病率的显着上升以及政府对酵母菌感染疾病创新疗法的资助增加。全球酵母菌感染疾病治疗市场的未来看起来充满希望，零售药局/药局、医院药局、专卖店和线上销售市场都有机会。

酵母菌感染疾病的细分治疗

这项研究包括按治疗类型、适应症、剂型、分销管道和地区对全球酵母菌感染疾病治疗的预测。

酵母感染疾病治疗市场洞察

Lucintel 预计锭剂/胶囊由于其尺寸多样且保质期长，在预测期内仍将是最大的细分市场。

在这个市场中，零售药局/药局将继续成为最大的细分市场。

由于感染疾病和酵母菌感染疾病的频率不断增加，北美在预测期内可能仍然是最大的地区。

常问问题

Q1.市场规模为：

A1. 到 2030 年，全球酵母菌感染疾病治疗市场预计将达到 79 亿美元。

Q2.市场成长预测是多少：

A2. 2024年至2030年，全球酵母菌感染疾病治疗市场预计将以4.6%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素是：

A3. 该市场的主要驱动力是自体免疫疾病和酵母菌感染疾病的增加、感染疾病和过敏性疾病发病率的显着上升以及政府对酵母菌感染疾病创新治疗的资助增加。

Q4.市场的主要细分市场是：

A4. 全球酵母菌感染疾病治疗市场前景广阔，零售药局/药局、医院药局、专卖店和线上销售市场都有机会。

Q5.市场的主要企业是：

A5. 主要的酵母菌感染疾病治疗公司有：

  • Astellas Pharma
  • Astra Zeneca
  • Abbott Laboratories
  • Allergan
  • Brundavan Laboratories
  • Bayer
  • Corden Pharma
  • Merck & Co
  • Novartis
  • Pfizer

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，锭剂/胶囊由于尺寸多样且保质期长，在预测期内将继续成为最大的细分市场。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 由于感染疾病地区阴道和感染疾病的频率不断增加，在预测期内，北美将继续成为最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球酵母感染疾病治疗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球酵母感染疾病治疗市场趋势（2018-2023）与预测（2024-2030）
  • 按治疗类型分類的全球酵母感染疾病治疗市场
    • Azole
    • 多基因
    • Echinocandins
    • 其他的
  • 按适应症分類的全球酵母感染疾病治疗市场
    • 生殖器念珠菌症
    • 侵袭性念珠菌症
    • 口咽/食道念珠菌症
    • 其他的
  • 全球酵母感染疾病治疗市场（按剂型）
    • 粉末
    • 乳膏/软膏
    • 锭剂/胶囊
    • 其他的
  • 按分销管道分類的全球酵母感染疾病治疗市场
    • 零售药局/药局
    • 医院药房
    • 专卖店
    • 网上销售
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球酵母感染疾病治疗市场（按地区）
  • 北美酵母感染疾病治疗市场
  • 欧洲酵母感染疾病治疗市场
  • 亚太酵母感染疾病治疗市场
  • 其他地区酵母菌感染疾病治疗市场

第五章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球酵母感染疾病治疗市场成长机会（依治疗类型）
    • 全球酵母感染疾病治疗市场成长机会（按适应症）
    • 全球酵母感染疾病治疗市场成长机会（按剂型）
    • 全球酵母感染疾病治疗市场成长机会（按分销管道）
    • 全球酵母感染疾病治疗市场按地区成长机会
  • 全球酵母菌感染疾病治疗市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球酵母感染疾病治疗市场的产能扩张
    • 全球酵母菌感染疾病治疗市场的合併、收购与合资企业
    • 认证和许可

第七章主要企业概况

  • Astellas Pharma
  • Astra Zeneca
  • Abbott Laboratories
  • Allergan
  • Brundavan Laboratories
  • Bayer
  • Corden Pharma
  • Merck & Co
  • Novartis
  • Pfizer
简介目录

Yeast Infection Treatment Trends and Forecast

The future of the global yeast infection treatment market looks promising with opportunities in the retail pharmacy/drug store, hospital pharmacy, specialty store, and online sale markets. The global yeast infection treatment market is expected to reach an estimated $7.9 billion by 2030 with a CAGR of 4.6% from 2024 to 2030. The major drivers for this market are increase in autoimmune disorders and yeast infections, significant rise in the incidence of infectious diseases and allergy disorders, and growing funding from the government for innovative therapies for yeast infections.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Yeast Infection Treatment by Segment

The study includes a forecast for the global yeast infection treatment by treatment type, indication, form, distribution channel, and region.

Yeast Infection Treatment Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:

  • Azoles
  • Polygene
  • Echinocandin
  • Others

Yeast Infection Treatment Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

  • Genital Candidiasis
  • Invasive Candidiasis
  • Oropharyngeal/Esophageal Candidiasis
  • Others

Yeast Infection Treatment Market by Form [Shipment Analysis by Value from 2018 to 2030]:

  • Powders
  • Creams/Ointments
  • Tablets/Capsules
  • Others

Yeast Infection Treatment Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Retail Pharmacies/Drug Stores
  • Hospital Pharmacies
  • Specialty Stores
  • Online Sales
  • Others

Yeast Infection Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Yeast Infection Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies yeast infection treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the yeast infection treatment companies profiled in this report include-

  • Astellas Pharma
  • Astra Zeneca
  • Abbott Laboratories
  • Allergan
  • Brundavan Laboratories
  • Bayer
  • Corden Pharma
  • Merck & Co
  • Novartis
  • Pfizer

Yeast Infection Treatment Market Insights

Lucintel forecasts that tablets/capsule will remain the largest segment over the forecast period because they come in various sizes and have a longer shelf life.

Within this market, retail pharmacy/drug store will remain the largest segment.

North America will remain the largest region over the forecast period due to increase in the frequency of vaginal infections and yeast infections in the region.

Features of the Global Yeast Infection Treatment Market

Market Size Estimates: Yeast infection treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Yeast infection treatment market size by treatment type, indication, form, distribution channel, and region in terms of value ($B).

Regional Analysis: Yeast infection treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different treatment type, indication, form, distribution channel, and regions for the yeast infection treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the yeast infection treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the yeast infection treatment market size?

Answer: The global yeast infection treatment market is expected to reach an estimated $7.9 billion by 2030.

Q2. What is the growth forecast for yeast infection treatment market?

Answer: The global yeast infection treatment market is expected to grow with a CAGR of 4.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the yeast infection treatment market?

Answer: The major drivers for this market are increase in autoimmune disorders and yeast infections, significant rise in the incidence of infectious diseases and allergy disorders, and growing funding from the government for innovative therapies for yeast infections.

Q4. What are the major segments for yeast infection treatment market?

Answer: The future of the global yeast infection treatment market looks promising with opportunities in the retail pharmacy/drug store, hospital pharmacy, specialty store, and online sale markets.

Q5. Who are the key yeast infection treatment market companies?

Answer: Some of the key yeast infection treatment companies are as follows:

  • Astellas Pharma
  • Astra Zeneca
  • Abbott Laboratories
  • Allergan
  • Brundavan Laboratories
  • Bayer
  • Corden Pharma
  • Merck & Co
  • Novartis
  • Pfizer

Q6. Which yeast infection treatment market segment will be the largest in future?

Answer: Lucintel forecasts that tablets/capsule will remain the largest segment over the forecast period because they come in various sizes and have a longer shelf life.

Q7. In yeast infection treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increase in the frequency of vaginal infections and yeast infections in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the yeast infection treatment market by treatment type (azoles, polygene, echinocandin, and others), indication (genital candidiasis, invasive candidiasis, oropharyngeal/esophageal candidiasis, and others), form (powders, creams/ointments, tablets/capsules, and others), distribution channel (retail pharmacies/drug stores, hospital pharmacies, specialty stores, online sales, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Yeast Infection Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Yeast Infection Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Yeast Infection Treatment Market by Treatment Type
    • 3.3.1: Azoles
    • 3.3.2: Polygene
    • 3.3.3: Echinocandin
    • 3.3.4: Others
  • 3.4: Global Yeast Infection Treatment Market by Indication
    • 3.4.1: Genital Candidiasis
    • 3.4.2: Invasive Candidiasis
    • 3.4.3: Oropharyngeal/Esophageal Candidiasis
    • 3.4.4: Others
  • 3.5: Global Yeast Infection Treatment Market by Form
    • 3.5.1: Powders
    • 3.5.2: Creams/Ointments
    • 3.5.3: Tablets/Capsules
    • 3.5.4: Others
  • 3.6: Global Yeast Infection Treatment Market by Distribution Channel
    • 3.6.1: Retail Pharmacies/Drug Stores
    • 3.6.2: Hospital Pharmacies
    • 3.6.3: Specialty Stores
    • 3.6.4: Online Sales
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Yeast Infection Treatment Market by Region
  • 4.2: North American Yeast Infection Treatment Market
    • 4.2.1: North American Yeast Infection Treatment Market by Form: Powders, Creams/Ointments, Tablets/Capsules, and Others
    • 4.2.2: North American Yeast Infection Treatment Market by Distribution Channel: Retail Pharmacies/Drug Stores, Hospital Pharmacies, Specialty Stores, Online Sales, and Others
  • 4.3: European Yeast Infection Treatment Market
    • 4.3.1: European Yeast Infection Treatment Market by Form: Powders, Creams/Ointments, Tablets/Capsules, and Others
    • 4.3.2: European Yeast Infection Treatment Market by Distribution Channel: Retail Pharmacies/Drug Stores, Hospital Pharmacies, Specialty Stores, Online Sales, and Others
  • 4.4: APAC Yeast Infection Treatment Market
    • 4.4.1: APAC Yeast Infection Treatment Market by Form: Powders, Creams/Ointments, Tablets/Capsules, and Others
    • 4.4.2: APAC Yeast Infection Treatment Market by Distribution Channel: Retail Pharmacies/Drug Stores, Hospital Pharmacies, Specialty Stores, Online Sales, and Others
  • 4.5: ROW Yeast Infection Treatment Market
    • 4.5.1: ROW Yeast Infection Treatment Market by Form: Powders, Creams/Ointments, Tablets/Capsules, and Others
    • 4.5.2: ROW Yeast Infection Treatment Market by Distribution Channel: Retail Pharmacies/Drug Stores, Hospital Pharmacies, Specialty Stores, Online Sales, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Yeast Infection Treatment Market by Treatment Type
    • 6.1.2: Growth Opportunities for the Global Yeast Infection Treatment Market by Indication
    • 6.1.3: Growth Opportunities for the Global Yeast Infection Treatment Market by Form
    • 6.1.4: Growth Opportunities for the Global Yeast Infection Treatment Market by Distribution Channel
    • 6.1.5: Growth Opportunities for the Global Yeast Infection Treatment Market by Region
  • 6.2: Emerging Trends in the Global Yeast Infection Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Yeast Infection Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Yeast Infection Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Astellas Pharma
  • 7.2: Astra Zeneca
  • 7.3: Abbott Laboratories
  • 7.4: Allergan
  • 7.5: Brundavan Laboratories
  • 7.6: Bayer
  • 7.7: Corden Pharma
  • 7.8: Merck & Co
  • 7.9: Novartis
  • 7.10: Pfizer